drugset / Trial / NCT05347381

Selinexol Combined With Dexamethasone in the Treatment of CAEBV

NCT05347381 ↗

Phase 3 Unknown 6 enrolled Beijing Friendship Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study is a single-center, prospective, observational clinical study to evaluate the Effecive and Safty of Selinexol and Dexamethasone in CAEBV

Timeline

Start
2022-05-01
Primary completion
2025-04-01
Completion
2025-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 1.5 mg Oral
Subject Selinexol Unknown 60 mg Oral